HEGDE SHARATHCHANDRA S 4
4 · Theravance Biopharma, Inc. · Filed Mar 6, 2019
Insider Transaction Report
Form 4
HEGDE SHARATHCHANDRA S
SVP, Research
Transactions
- Sale
Ordinary Shares
2019-03-04$25.06/sh−3,343$83,764→ 270,134 total - Sale
Ordinary Shares
2019-03-05$24.50/sh−5,690$139,405→ 264,444 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices from $25.00 to $25.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices from $24.4953 to $24.515. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.